Announcements Trials

Conditions

Other 9Gynecologic 5Genitourinary 2Breast 1Gastrointestinal 1Head & Neck 1Thoracic 1

Drug Classes

Anti-PD-1 16Anti-CD20 10Anti-VEGFR 10Bcr-Abl inhibitor 10MTOR inhibitor 10Taxane 9VEGFR inhibitor 9Anti-HER2 7Megakaryocyte growth factor 7Anti-EGFR 6EGFR inhibitor 6Immunomodulatory drugs (IMiDs) 6MEK inhibitor 6ALK inhibitor 5Antifolate 5BTK inhibitor 5Multikinase inhibitor 5Nitrogen mustard 5Anti-PD-L1 4JAK inhibitor 4Platinum agent 4Proteasome inhibitor 4Anti-RANKL 3Asparagine-specific enzyme 3BRAF inhibitor 3HDAC inhibitor 3Non-taxane microtubule dynamics inhibitor 3Anthracycline 2Anti-CD19-CD3 bispecific 2Anti-CD30 ADC 2Anti-CD38 2Anti-CTLA-4 2Aromatase inhibitor third generation 2CDK inhibitor 2CYP17 inhibitor 2Erythrocyte growth factor 2Factor IXa/Xa bridging 2Fluoropyrimidine 2Granulocyte colony-stimulating factor 2Low molecular weight heparin 2PARP inhibitor 2Pyrimidine analog 2SMO inhibitor 2Alkylating agent 1Anti-C5 1Anti-CSF1R 1Anti-EGFR-HGFR bispecific 1Anti-GD2 1Anti-HER2 ADC 1Anti-IL-2R immunotoxin 1Anti-IL-6 1Anti-P-selectin 1Anti-PDGFR 1Anti-SLAMF7 1Anti-dabigatran antibody fragment 1Anti-vWF 1Antimetabolite 1Bcl-2 inhibitor 1CXCR4 inhibitor 1Cellular therapy 1Chemotherapy protective agent 1EDTA derivative 1ERBB2 inhibitor 1Estrogen receptor inhibitor 1Factor Xa inhibitor 1GnRH antagonist 1HIF-2a inhibitor 1Hemoglobin S polymerization inhibitor 1Interferon 1Iron chelating agent 1Oncolytic viral therapy 1PI3K alpha inhibitor 1PI3K delta inhibitor 1Profibrinolytic 1Purine analog 1ROCK2 inhibitor 1Replacement therapy 1SYK inhibitor 1Second-generation nonsteroidal antiandrogen 1Selective estrogen receptor modulator 1Somatostatin analog 1TGF-beta inhibitor 1TRK inhibitor 1Topoisomerase I inhibitor 1Triazene 1Vinca alkaloid 1
Taxane × Other × Clear all

9 Announcements

2014-12-12

Ramucirumab (Cyramza)

Drugs
Cyramza (ramucirumab) · Anti-VEGFR antibody, docetaxel · Taxane, paclitaxel · Taxane
2014-11-14

Bevacizumab solution in combination with Paclitaxel

Drugs
Avastin (bevacizumab solution for intravenous infusion) · Anti-VEGFR antibody, Avastin (intravenous infusion) , paclitaxel · Taxane, Avastin (bevacizumab) · Anti-VEGFR antibody
2014-11-05

Ramucirumab in combination with paclitaxel

Drugs
Cyramza (ramucirumab) · Anti-VEGFR antibody, paclitaxel · Taxane
2013-09-30

Pertuzumab Injection

Drugs
PERJETA (pertuzumab) · Anti-HER2 antibody, trastuzumab · Anti-HER2 antibody, docetaxel · Taxane
2013-09-06

Paclitaxel

Drug
Abraxane (paclitaxel) · Taxane
2012-06-08

FDA Approves Pertuzumab

Drugs
PERJETA (pertuzumab) · Anti-HER2 antibody, trastuzumab · Anti-HER2 antibody, docetaxel · Taxane
2010-06-17

Cabazitaxel

Drug
Jevtana (cabazitaxel) · Taxane
2008-02-22

Bevacizumab Granted Accelerated Approval

Drugs
Avastin (bevacizumab) · Anti-VEGFR antibody, paclitaxel · Taxane
2007-09-28

FDA Approves Docetaxel

Drug
Taxotere Injection Concentrate (docetaxel) · Taxane
Data powered by HemOnc (CC BY 4.0) Colophon ⚡